Study to Compare a Mono Atezolizumab Window Followed by a Atezolizumab - CTX Therapy With Atezolizumab - CTX Therapy

Clinical trial NCT04770272 · TERMINATED

Trial details

NCT number: NCT04770272
Sponsor: Palleos Healthcare GmbH
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Triple-negative Breast Cancer

Start date: 2021-03-01
Primary completion: 2023-07-06
Enrollment: 442

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.